Whitehawk Therapeutics, Inc 10-Q for FY2025 Q2
Whitehawk Therapeutics, Inc. (WHWK)
10-Q
2025-08-07
For: 2025-06-30
View Original
Added on
April 08, 2026
About this 10-Q
Whitehawk Therapeutics, Inc filed this 10-Q on August 7, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).
Headline figures
Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $6.18M a year earlier
- Net loss
- $52.62M
- compared with a net loss of $14.58M a year earlier
- Diluted EPS
- -$0.76
- compared with -$0.54 a year earlier